Jamie L. DellaGatta

Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes

Sachet A. Shukla, Michael S. Rooney, Mohini Rajasagi et al. · Nature Biotechnology · 2015 · 670 citations · Full text

Hla, Histocompatibility, Cancer-associated Somatic Mutations +11

Efficacy of the HSP90 inhibitor 17-AAG in human glioma cell lines and tumorigenic glioma stem cells

Claire Sauvageot, Jessica L. Weatherbee, Santosh Kesari et al. · Neuro-Oncology · 2008 · 145 citations · Full text

Neuro-oncology, Cell Cycle Axis, Signal Transduction Pathways +13

Beneficial effects of combining nilotinib and imatinib in preclinical models of BCR-ABL+ leukemias

Ellen Weisberg, Laurie Catley, Renee D. Wright et al. · Blood · 2006 · 106 citations · Full text

Targeting the <i>AIB1</i> Oncogene through Mammalian Target of Rapamycin Inhibition in the Mammary Gland

Maria I. Torres‐Arzayus, Jing Yuan, Jamie L. DellaGatta et al. · Cancer Research · 2006 · 48 citations · Full text

Lonafarnib (SCH66336) improves the activity of temozolomide and radiation for orthotopic malignant gliomas

Deviney M. Chaponis, Jessica W. Barnes, Jamie L. DellaGatta et al. · Journal of Neuro-Oncology · 2011 · 29 citations · Full text

Neuro-oncology, Oncology, Medicine +9